ATCG Post

BRCA1 and BRCA2 Screening & Prognosis The first question from the audience concerned BRCA1 and BRCA2, as there are two schools of thought and people in the medical fraternity consider one as a screening and the other as a review, where when treatment is started, BRCA1 and BRCA2 are considered to see the prognosis. Is

There’s simply no way any person can be abreast of all the knowledge. We need to interact with people; we cannot sit alone in a clinic and treat anymore. We need to consult with the pathologist, molecular oncologist, pharmacist, and others. We have to get patients into clinical trials, get patients into drugs that will

Clinical Applications of Next-Generation Sequencing in Precision Oncology The panel members included: Dr. Saadvik Raghuram, a renowned oncologist at Medicover Cancer Institutes who completed his MBBS from JSS Medical College and DM in Medical Oncology and MD in Radiation Oncology; Dr. Vamshi Krishna, AIG Hospitals; Dr. Sudha Sinha, CARE Hospitals; Dr. Shrikar Kumar, Onco Cancer

The session began with a brief presentation by Dr. Kalyan Uppaluri, Managing Director, K&H Personalized Medicine, on how and why to incorporate molecular biology and genetic science into clinical practice, supported by a few figures. Medicines Still Under Trial for Chronic Conditions According to global research, there were 767 medicines in phases I, II, and

Mr. Jayesh Ranjan, IAS and Advisor for IT Government of Telangana, addressed the delegation at the ATCG Life Knowledge Meet on October 29th, 2022, at Hotel Daspalla. He spoke about the need for medical institutions like Yashoda, AIG, and CARE Hospitals to take the initiative to guide the industry. He also discussed the challenges for

According to a study conducted by Oregon State University, patients of cystic fibrosis can benefit greatly by taking vitamin C and E supplements as these help in reducing inflammation and related oxidative stress. The findings of the study were published in the journal, Nutrients. Cystic fibrosis is a genetic disease marked by lung inflammation and

The findings of a recent study suggest that blood omega-3 fatty acid (FA) is inversely related to inflammatory gene expression (IGE) inn multiple sclerosis (MS). The results of the study were published in the journal, Nutrients. It included 1353 participants from 13 cohort between the time frame of 3 to 144 weeks. The results obtained